Articles, App Notes, Case Studies, & White Papers
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch
8/7/2025
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
How Long Is Your RTSM Risk Mitigation List?
11/21/2024
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
Benefits Of Implementing EDC & Medical Coding With RTSM
3/17/2023
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
4/18/2024
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Safeguarding Cell Therapy Cryopreservation: Primary Containers
5/20/2024
Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
Increasing Efficiency And Reducing Drug Waste
10/2/2025
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies
8/1/2022
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Understanding Injectable Drug Container Closure Systems
6/20/2024
Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
8/30/2023
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
From Frustration To Organization: An SSO Platform For Trial Sites
5/2/2025
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.